New celiac diagnostic test passes first safety check in small study
Diagnosis
Completed
This early-stage study tested the safety of a single dose of HB-2121, a potential diagnostic for celiac disease, in 18 healthy adults and people with celiac disease. Researchers monitored side effects and how the drug moved through the body over 30 days. The goal was to see if HB…
Phase: PHASE1 • Sponsor: Nielsen Fernandez-Becker • Aim: Diagnosis
Last updated May 17, 2026 05:07 UTC